Group 3 (<50% tumour necrosis)
| Age (years) | Sex | Maximum tumour size (mm) | pTNM stage | Fuhrman nuclear grade | Tumour subtype | Follow up (months) |
|---|---|---|---|---|---|---|
| DOOC, died of other causes; LTFU, lost to follow up; NED, no evidence of disease. | ||||||
| 70 | M | 240 | 3 | 2 | Clear cell | DOOC (3) |
| 46 | F | 85 | 3b | 2 | Clear cell | NED (13) |
| 58 | F | 75 | 2 | 2 | Clear cell | LTFU |
| 79 | M | 350 | 2 | 1 | Clear cell | NED (24) |
| 63 | F | 25 | 1 | 2 | Clear cell | NED (25) |
| 45 | F | 170 | 3 | 2 | Clear cell | Metastasis (15) |
| 63 | M | 70 | 1 | 2 | Clear cell | NED (21) |
| 71 | M | 32 | 1 | 2 | Clear cell | NED (39) |
| 68 | M | 70 | 3 | 2 | Clear cell | NED (39) |
| 61 | M | 200 | 2 | 2 | Clear cell | NED (37) |
| 64 | M | 80 | 3b | 1 | Clear cell | Metastasis (33) |
| 67 | M | 50 | 3b | 2 | Clear Cell | Metastasis (5) |
| 44 | M | 40 | 1 | 2 | Clear cell | LTFU |
| 64 | M | 150 | 3a | 3 | Clear cell | Metastasis (16) |
| 53 | F | 65 | 1 | 2 | Clear cell | NED (60) |
| 44 | M | 140 | 3 | 3 | Clear cell | NED (57) |
| 80 | F | 190 | 3 | 3 | Clear cell | Died (<1) |
| 47 | F | 200 | 2 | 2 | Clear cell | NED (73) |
| 73 | M | 85 | 3 | 2 | Clear cell | Metastasis (31) |
| 73 | M | 120 | 2 | 2 | Papillary | NED (47) |